Ryan Martins - 03 Jan 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role: Chief Financial Officer
Signature: /s/ Ryan A. Murr, as attorney-in-fact for Ryan Martins
Issuer symbol: ETNB
Transactions as of: 03 Jan 2023
Net transactions value: -$74,397
Form type: 4
Filing time: 05 Jan 2023, 17:03:06 UTC
Previous filing: 30 Sep 2022
Next filing: 03 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ETNB	Common Stock	Sale	$74,397	-5,947	-14%	$12.51	36,368	03 Jan 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $11.94 to $12.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.

Content

This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $11.94 to $12.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.